New 8-nitroquinolinone derivative displaying submicromolar in vitro activities against both Trypanosoma brucei and cruzi

Julien Pedron, Clotilde Boudot, Jean-yves Brossas, Emilie Pinault, Sandra Bourgeade-Delmas, Alix Sournia-Saquet, Elisa Boutet-Robinet, Alexandre Destere, Antoine Tronnet, Justine Bergé, Colin Bonduelle, Céline Deraeve, Genevieve Pratviel, Jean-Luc Stigliani, Luc Paris, Dominique Mazier, Sophie Corvaisier, Marc Since, Aurélie Malzert-Freon, Susan WyllieRachel Milne, Alan H. Fairlamb, Alexis Valentin, Bertrand Courtioux, Pierre Verhaeghe

Research output: Contribution to journalArticle

40 Downloads (Pure)

Abstract

An antikinetoplastid pharmacomodulation study was conducted at position 6 of the 8-nitroquinolin-2(1H)-one pharmacophore. Fifteen new derivatives were synthesized and evaluated in vitro against L. infantum, T. brucei brucei, and T. cruzi, in parallel with a cytotoxicity assay on the human HepG2 cell line. A potent and selective 6-bromo-substituted antitrypanosomal derivative 12 was revealed, presenting EC 50 values of 12 and 500 nM on T. b. brucei trypomastigotes and T. cruzi amastigotes respectively, in comparison with four reference drugs (30 nM ≤ EC 50 ≤ 13 μM). Moreover, compound 12 was not genotoxic in the comet assay and showed high in vitro microsomal stability (half life >40 min) as well as favorable pharmacokinetic behavior in the mouse after oral administration. Finally, molecule 12 (E° = -0.37 V/NHE) was shown to be bioactivated by type 1 nitroreductases, in both Leishmania and Trypanosoma, and appears to be a good candidate to search for novel antitrypanosomal lead compounds.

Original languageEnglish
Pages (from-to)464-472
Number of pages9
JournalACS Medicinal Chemistry Letters
Volume11
Issue number4
Early online date6 Feb 2020
DOIs
Publication statusPublished - 9 Apr 2020

Keywords

  • 8-nitroquinolin-2(1 H)-ones
  • NTR1
  • Trypanosoma brucei brucei
  • Trypanosoma cruzi
  • redox potentials

Fingerprint Dive into the research topics of 'New 8-nitroquinolinone derivative displaying submicromolar in vitro activities against both Trypanosoma brucei and cruzi'. Together they form a unique fingerprint.

  • Projects

    Cite this

    Pedron, J., Boudot, C., Brossas, J., Pinault, E., Bourgeade-Delmas, S., Sournia-Saquet, A., Boutet-Robinet, E., Destere, A., Tronnet, A., Bergé, J., Bonduelle, C., Deraeve, C., Pratviel, G., Stigliani, J-L., Paris, L., Mazier, D., Corvaisier, S., Since, M., Malzert-Freon, A., ... Verhaeghe, P. (2020). New 8-nitroquinolinone derivative displaying submicromolar in vitro activities against both Trypanosoma brucei and cruzi. ACS Medicinal Chemistry Letters, 11(4), 464-472. https://doi.org/10.1021/acsmedchemlett.9b00566